Trials / Completed
CompletedNCT01605851
GORE® Septal Occluder European Union Clinical Evaluation
GORE® Septal Occluder EU Clinical Evaluation: A Study to Evaluate Clinical Success and Performance in the Treatment of Transcatheter Closure of Patent Foramen Ovale (PFO)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- W.L.Gore & Associates · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate clinical success and performance of the GORE® Septal Occluder when used for percutaneous, transcatheter closure of Patent Foramen Ovale (PFO).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Closure, Foramen Ovale |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2014-01-01
- Completion
- 2014-04-01
- First posted
- 2012-05-25
- Last updated
- 2014-04-24
Locations
9 sites across 5 countries: Denmark, Germany, Italy, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT01605851. Inclusion in this directory is not an endorsement.